Dynamic Technology Lab Private Ltd Takes $2.03 Million Position in Encompass Health Co. (NYSE:EHC)

Dynamic Technology Lab Private Ltd purchased a new position in Encompass Health Co. (NYSE:EHC) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 21,940 shares of the company’s stock, valued at approximately $2,026,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of EHC. ExodusPoint Capital Management LP bought a new position in Encompass Health in the 4th quarter valued at about $6,268,000. Cinctive Capital Management LP boosted its holdings in shares of Encompass Health by 143.1% in the 4th quarter. Cinctive Capital Management LP now owns 93,312 shares of the company’s stock valued at $8,617,000 after purchasing an additional 54,931 shares in the last quarter. Trexquant Investment LP bought a new position in shares of Encompass Health in the fourth quarter worth about $3,885,000. Geode Capital Management LLC lifted its holdings in Encompass Health by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 1,679,774 shares of the company’s stock worth $155,176,000 after buying an additional 6,164 shares during the period. Finally, Franklin Resources Inc. increased its position in Encompass Health by 12.3% during the 4th quarter. Franklin Resources Inc. now owns 786,469 shares of the company’s stock valued at $72,630,000 after purchasing an additional 86,448 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Stock Performance

Shares of EHC opened at $98.14 on Friday. The firm has a market capitalization of $9.88 billion, a P/E ratio of 22.00, a P/E/G ratio of 2.31 and a beta of 0.87. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. Encompass Health Co. has a 52 week low of $78.53 and a 52 week high of $104.55. The stock has a 50 day moving average price of $99.25 and a two-hundred day moving average price of $97.67.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Equities analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.17 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.69%. Encompass Health’s payout ratio is presently 15.25%.

Wall Street Analysts Forecast Growth

A number of analysts have commented on EHC shares. KeyCorp upped their price target on shares of Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Monday, February 10th. William Blair reiterated an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. StockNews.com cut Encompass Health from a “buy” rating to a “hold” rating in a report on Thursday. Barclays increased their target price on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, February 7th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. One investment analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, Encompass Health presently has a consensus rating of “Buy” and an average price target of $107.67.

Insider Activity

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the business’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.10% of the stock is currently owned by corporate insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.